Atlas Trials

Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC

Clinical trial NCT03432949 · UNKNOWN

Trial details

NCT number
NCT03432949
Sponsor
University Health Network, Toronto
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Metastatic Prostate Cancer
Start date
2018-02-23
Primary completion
2023-09-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.